CORRECTED-UPDATE 1-FDA approves Pfizer’s leukemia drug

Sept 1 (Reuters) – The U.S. Food and Drug Administration(FDA) on Friday approved Pfizer Inc’s drug, Mylotarg,for certain patients with acute myeloid leukemia (AML).
The post CORRECTED-UPDATE 1-FDA approves Pfizer’s leukemia drug appeared first on RocketNews | Top News Stories From Around the Globe.